Drugs / Menaquinone
Menaquinone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02876354 | Aug → Sep 2016 | calcinosis | Saint-Joseph University | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06707909 Comparator | Feb → Oct 2025 overdue | — | Cairo University | Recruiting | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Menaquinone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02876354 ↗ |
| Known as | J39.473D | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297659 ↗ |
| Known as | Menaquinone 5 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297659 ↗ |
| Known as | vitamin k2 (Menaquinone) | “vitamin k2 (Menaquinone)” NCT06707909 ↗ |
| Known as | Vitamin k2(25) | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297659 ↗ |
| Known as | Vitamin mk 5 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297659 ↗ |
| Modality | Small molecule | — CHEMBL4297659 ↗ |